(Q37078706)

18 August 2017

Women's decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid. (English)

1 reference

18 August 2017

1 reference

1 reference

Brian J Zikmund-Fisher

object named as

Brian J Zikmund-Fisher

2

0 references

Angela Fagerlin

1

object named as

Angela Fagerlin

1 reference

18 August 2017

15

Peter A Ubel

1 reference

18 August 2017

5

Jennifer B McClure

1 reference

18 August 2017

Vijayan Nair

3

1 reference

18 August 2017

Holly A Derry

4

1 reference

18 August 2017

Sarah Greene

6

1 reference

18 August 2017

Azadeh Stark

7

1 reference

18 August 2017

Sharon Hensley Alford

8

1 reference

18 August 2017

Paula Lantz

9

1 reference

18 August 2017

Daniel F Hayes

10

1 reference

18 August 2017

Cheryl Wiese

11

1 reference

18 August 2017

Sarah Claud Zweig

12

1 reference

18 August 2017

Rosemarie Pitsch

13

1 reference

18 August 2017

Aleksandra Jankovic

14

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

Breast Cancer Research and Treatment

18 August 2017

1 reference

18 August 2017

119

1 reference

18 August 2017

3

1 reference

18 August 2017

613-620

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-009-0618-4

18 August 2017

0 references

cites work

Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence of pictographs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736824

"Why take it if you don't have anything?" breast cancer risk perceptions and prevention choices at a public hospital

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736824

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736824

Development and evaluation of a breast cancer prevention decision aid for higher-risk women

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736824

Decision aids for patients facing health treatment or screening decisions: systematic review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736824

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736824

The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736824

Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736824

Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736824

Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736824

Patient reluctance toward tamoxifen use for breast cancer primary prevention

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736824

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19908143

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10549-009-0618-4

1 reference

18 August 2017

1 reference

18 August 2017

1 reference